These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3134218)

  • 1. Escherichia coli K1 in urinary tract infections.
    Reina J; Salva F; Gil J; Alomar P
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):205. PubMed ID: 3134218
    [No Abstract]   [Full Text] [Related]  

  • 2. Occurrence of K1, K5 and O antigens in Escherichia coli isolates from patients with urinary tract infections or bacteraemia.
    Devine DA; Robinson L; Roberts AP
    J Med Microbiol; 1989 Dec; 30(4):295-9. PubMed ID: 2481040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of serological groups of Escherichia coli with urinary infections].
    de Oliveira EF; Andrade JR; Pereira AA; Marques EA; Suassuna I
    AMB Rev Assoc Med Bras; 1977 Jun; 23(6):217-9. PubMed ID: 343192
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
    Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
    Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract infectivity or R strains of Escherichia coli carrying various virulence factors.
    Kétyi I; Naumann G; Nimmich W
    Acta Microbiol Hung; 1983; 30(2):155-61. PubMed ID: 6140809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple technique for detecting K1 antigen of Escherichia coli.
    Devine DA; Roberts AP; Rowe B
    J Clin Pathol; 1990 Jan; 43(1):76-8. PubMed ID: 2179274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model.
    Verweij-van Vught AM; van den Bosch JF; Namavar F; Sparrius M; MacLaren DM
    J Med Microbiol; 1983 May; 16(2):147-55. PubMed ID: 6341596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fimbrial serotypes of Escherichia coli strains isolated from extra-intestinal infections.
    De Ree JM; Van den Bosch JF
    J Med Microbiol; 1989 Jun; 29(2):95-9. PubMed ID: 2471835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria.
    Myerowitz RL; Schneerson R; Robbins JB; Turck M
    Lancet; 1972 Aug; 2(7771):250-3. PubMed ID: 4114507
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of Escherichia coli with capsular antigen K1 isolated from urinary tract infection on the joint action of cefotaxime and normal human serum.
    Jankowski S; Franiczek R
    Nephron; 1994; 68(4):519-20. PubMed ID: 7870242
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of ozone on the susceptibility of Escherichia coli K1 to the bactericidal action of serum.
    Jankowski S; Cisowska A; Doroszkiewicz W
    Folia Microbiol (Praha); 1996; 41(5):395-400. PubMed ID: 9131796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septicemia caused by cysteine-dependent Escherichia coli.
    Yuen KY; Seto WH; Tsui KH; Hui WT
    J Clin Microbiol; 1990 May; 28(5):1047-8. PubMed ID: 2191004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Escherichia coli K1 antigen.
    Cross A; Orskov I; Orskov F; Sadoff J; Gemski P
    J Clin Microbiol; 1984 Aug; 20(2):302-4. PubMed ID: 6436300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characteristics, phage patterns, and O1 factor analysis of Escherichia coli O1:K1:H7:F11 and O1:K1:H-:F9 strains isolated from patients with urinary tract infections.
    Nimmich W; Zingler G
    Med Microbiol Immunol; 1984; 173(2):75-85. PubMed ID: 6208464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dulcitol test in strains of Escherichia coli isolated from urinary infections and feces].
    Zilleruelo G; Saieh C; Córdova M
    Rev Chil Pediatr; 1977; 48(2):89-91. PubMed ID: 360316
    [No Abstract]   [Full Text] [Related]  

  • 17. Virulence characteristics of Escherichia coli in nosocomial urinary tract infection.
    Ikäheimo R; Siitonen A; Kärkkäinen U; Mäkelä PH
    Clin Infect Dis; 1993 Jun; 16(6):785-91. PubMed ID: 7687152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of Escherichia coli. III. Correlation with Escherichia coli pathogenicity of haemolysin production, haemagglutinating capacity, antigens K1, K5, and colicinogenicity.
    Czirók E; Milch H; Csiszár K; Csik M
    Acta Microbiol Hung; 1986; 33(1):69-83. PubMed ID: 3529796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
    Straube E; Nimmich W; Broschewitz U; Naumann G
    Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation.
    Siitonen A; Martikainen R; Ikäheimo R; Palmgren J; Mäkelä PH
    Microb Pathog; 1993 Jul; 15(1):65-75. PubMed ID: 7692211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.